Are You Eligible for Monoclonal Antibody Treatment?

Eligibility for monoclonal antibody treatment depends on specific criteria set by the U.S. Food and Drug Administration (FDA) or the healthcare authority in your region. These criteria may vary based on the availability and authorization of monoclonal antibody treatments. Here are the general eligibility criteria for monoclonal antibody treatment against COVID-19 in the United States:

1. Mild or Moderate COVID-19 Symptoms:

- You should have a confirmed positive COVID-19 test result, either through a molecular or antigen test.

- You are experiencing mild or moderate symptoms of COVID-19 that began within the last 10 days. Symptoms can include fever, cough, shortness of breath, fatigue, muscle or body aches, headache, sore throat, nausea, vomiting, or diarrhea.

2. High Risk of Severe Illness:

- You have a high risk of developing severe COVID-19 due to certain underlying medical conditions or characteristics. These may include:

- Age 65 or older

- Certain chronic medical conditions, such as heart disease, obesity, diabetes, chronic kidney disease, chronic lung disease, or immunosuppressed conditions

- Pregnancy or recent pregnancy within the past 4 weeks

3. Not Fully Vaccinated or Not Eligible for Vaccination:

- You have not been fully vaccinated against COVID-19 (meaning you have not received the full recommended series of doses).

- You have a medical condition or history of severe allergic reactions that prevents you from receiving a COVID-19 vaccine or booster dose.

4. Other Considerations:

- You are at least 12 years of age (specific age criteria may vary, consult with your healthcare provider).

- Your healthcare provider may consider additional factors when determining your eligibility, such as your current health status, response to previous treatments, or other medications you may be taking.

It's important to note that monoclonal antibody treatments are not a substitute for COVID-19 vaccination. Vaccination remains the best preventive measure against severe illness, hospitalization, and death from COVID-19. If you meet the eligibility criteria, discuss with your healthcare provider whether monoclonal antibody treatment is right for you and when it should be administered.